General Information


DRACP ID  DRACP04437

Peptide Name  

Sequence  LCXIIKKIIKKIIKKII

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C93H176N22O16S

Absent amino acids  ADEFGHMNPQRSTVWY

Common amino acids  I

Mass  228622

Pl  11.1

Basic residues  6

Acidic residues  0

Hydrophobic residues  9

Net charge  6

Boman Index  1226

Hydrophobicity  111.18

Aliphatic Index  206.47

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34509120

Title  Rationally designed short cationic δΌͺ-helical peptides with selective anticancer activity

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19841

DRACP is developed by Dr.Zheng's team.